Diagnostyka Consilio
Diagnostyka Consilio operates the largest private pathomorphology laboratory network in Poland, performing over 1.5 million histopathology and cytology examinations annually for hospitals, clinics, and individual pathology practices via B2B contracts.
- Company typePrivate
- Founded2005
- HeadquartersLodz, Poland
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Diagnostyka Consilio does
Diagnostyka Consilio spółka z ograniczoną odpowiedzialnością is a privately held Polish pathology diagnostics company founded in 2005 and headquartered in Łódź, Poland. It operates the largest private network of pathomorphology laboratories in Poland, performing over 1,500,000 histopathological and cytological examinations annually across laboratory sites in Łódź and Warsaw. The company serves hospitals, clinics, individual pathology practices, and diagnostic specialists through B2B contractual arrangements supported by dedicated medical representatives.
The core service offering centers on pathomorphology diagnostics — histopathological examinations, cytological tests including liquid-based cytology (LBC), and biopsy analysis — delivered by a team comprising pathomorphologists, cytodiagnosticians, cytomorphologists, laboratory diagnosticians, and technicians. Operations are supported by ISO 9001:2015 quality certification, a license from the Polish Pathological Society (PTP), and a proprietary IT platform called E-CONSILIO that provides contracted healthcare facilities with secure, real-time online access to diagnostic results. Free nationwide transport of tissue materials in barcoded containers is bundled into the service.
Revenue is generated through contracted laboratory diagnostic services billed to healthcare providers on a recurring B2B basis; pricing is not publicly disclosed. Go-to-market relies on enterprise field sales through medical representatives assigned to contracted facilities, supplemented by an educational knowledge base, scientific materials, and collaboration with academic centers in Poland and abroad. Named customers include LUXMED Onkologia, Szpital im. Zeromskiego, Szpital MSWiA, Szpital Św. Rodziny, Salve Medica, and SPZOZ Ostrowia. The company has no disclosed external investors, parent company, M&A activity, or public funding rounds.
Diagnostyka Consilio firmographics
Firmographics- Name
- Diagnostyka Consilio
- Legal name
- Diagnostyka Consilio spółka z ograniczoną odpowiedzialnością
- Website
- https://consilio.pl
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Diagnostyka Consilio operates the largest private pathomorphology laboratory network in Poland, performing over 1.5 million histopathology and cytology examinations annually for hospitals, clinics, and individual pathology practices via B2B contracts.
- Ownership category
- akta.pro rank
Diagnostyka Consilio industry classification
Industry- Product category
- Pathology Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
Keywords
Where Diagnostyka Consilio is headquartered
LocationHeadquarters
- HQ city
- Lodz
- HQ country
- Poland
- HQ region
- Europe
Offices3 records
Markets served
Diagnostyka Consilio business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Laboratory Diagnostic Services: Pathomorphology diagnostic services including histopathology, cytology, and biopsy analysis for healthcare providers including hospitals, clinics, and pathology practices across Poland
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Diagnostyka Consilio product offering
Product offeringCore offering
Diagnostyka Consilio operates the largest private network of pathomorphology laboratories in Poland, performing histopathological and cytological examinations (including LBC cytology) on tissue materials referred by hospitals, clinics, and independent medical practices. The company provides free nationwide transport of specimens in barcoded containers and delivers results to contracted facilities through its proprietary E-CONSILIO online platform.
Product overview
Diagnostyka Consilio is Poland's largest non-public network of pathological anatomy laboratories, offering a comprehensive suite of diagnostic services centered on histopathological and cytological examinations. The portfolio includes the core E-CONSILIO proprietary IT platform providing online result access, complementary logistics and specimen transport services, educational knowledge resources, and specialized services such as LBC cytology. The company operates multiple laboratory sites across Poland, serving over 1 hospital, numerous outpatient clinics, and independent pathomorphologists.
Differentiator
Problem solved
Functional benefit
Products and services
- Histopathological and Cytological Examinations (Badania patomorfologiczne)
- Liquid-Based Cytology (LBC) Examinations (Badania cytologiczne LBC)
- Tissue Material Logistics and Transport Service (Logistyka i transport materiałów tkankowych)
- Paraffin Block and Tissue Section Lending Service (Wypożyczenie bloczków)
Quantifiable outcome
- Over 1,500,000 diagnostic tests performed annually
Companies that use Diagnostyka Consilio
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Diagnostyka Consilio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Diagnostyka Consilio partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Kliniczne Centrum Ginekologii, Położnictwa i Neonatologii w OpoluminorCollaboration with the Clinical Center of Gynecology, Obstetrics and Neonatology in Opole to provide free LBC cytology tests for midwives and nurses of the facility, supporting cervical cancer prevention and promoting regular examinations
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Diagnostyka Consilio competitors and assessment
Company assessmentEmerging players
- Genomed S.A. Genomed is a Polish diagnostics laboratory focused on molecular genetics and specialized testing with B2B services to clinicians. It overlaps with Consilio in advanced diagnostics demand from hospitals and may compete or partner as pathology menus converge toward molecular testing.
Regional players
- Invicta Diagnostics: Invicta operates clinical and diagnostic laboratories across northern and central Poland, including histopathology services. It overlaps with Consilio in private-clinic pathology demand in similar geographies.
- Laboratoria Medyczne badaj.to: badaj.to operates a regional network of medical laboratories in Poland offering pathology-adjacent and routine diagnostics. It is a smaller-scale competitor in overlapping procurement regions.
Broad incumbents
- Quest Diagnostics: Quest Diagnostics is a leading U.S. clinical laboratory and anatomic pathology provider. It serves as a structural benchmark for enterprise pathology services, proprietary result portals and population-scale logistics.
- Sonic Healthcare: Sonic Healthcare is a global medical diagnostics operator with significant anatomic pathology operations in Europe. It is comparable as a multi-country pathology platform pursuing scale and IT-enabled workflows.
- LabCorp (Laboratory Corporation of America): LabCorp is a global clinical laboratory network with extensive anatomic pathology and digital pathology capabilities. While not focused on Poland, it represents the global incumbent benchmark for outsourced pathology scale, IT integration and lab automation.
- Unilab (part of Synlab): Synlab operates Unilab and a wider European clinical diagnostics network including Poland. It is comparable as a multinational outsourced diagnostics provider competing for hospital pathology contracts across Europe.
Direct peers
- ALAB Laboratoria: ALAB Laboratoria operates one of the largest networks of medical laboratories in Poland with nationwide sample collection and B2B hospital contracts. It competes for the same enterprise pathology and clinical lab procurement pools as Consilio.
- Synevo (Medicover): Synevo is a European diagnostics chain owned by Medicover that provides laboratory and pathology services across Poland. Its multi-country infrastructure and Medicover clinic integration make it a direct comparable for outsourced pathology demand.
- Diagnostyka S.A. Diagnostyka S.A. is the largest private clinical diagnostics network in Poland, offering a broad menu including pathology, laboratory medicine and imaging. It competes head-to-head with Consilio on hospital pathology contracts while extending broader cross-sell, making it the closest scaled competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Diagnostyka Consilio social profiles
Digital presenceDiagnostyka Consilio compliance and trust
Trust signalCompliance2 records
Diagnostyka Consilio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diagnostyka Consilio leadership team
Management profileNumber of profiles
Diagnostyka Consilio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diagnostyka Consilio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diagnostyka Consilio
What does Diagnostyka Consilio do?
Diagnostyka Consilio operates the largest private network of pathomorphology laboratories in Poland, performing histopathological and cytological examinations (including LBC cytology) on tissue materials referred by hospitals, clinics, and independent medical practices. The company provides free nationwide transport of specimens in barcoded containers and delivers results to contracted facilities through its proprietary E-CONSILIO online platform.
Is Diagnostyka Consilio a public or private company?
Diagnostyka Consilio is a private company. It is classified as unknown and is currently operating.
When was Diagnostyka Consilio founded?
Diagnostyka Consilio was founded in 2005. It employs 101 to 250 people.
Where is Diagnostyka Consilio based?
Diagnostyka Consilio is headquartered in Lodz, Poland, in the Europe region.
How does Diagnostyka Consilio make money?
One revenue line is on record: laboratory Diagnostic Services.
Who are Diagnostyka Consilio's main competitors?
Genomed S.A. is listed as an emerging player. Regional players are Invicta Diagnostics and Laboratoria Medyczne badaj.to. Broad incumbents are Quest Diagnostics, Sonic Healthcare, LabCorp (Laboratory Corporation of America) and Unilab (part of Synlab). Direct peers are ALAB Laboratoria, Synevo (Medicover) and Diagnostyka S.A..
Does Diagnostyka Consilio have an API?
No public API is recorded for Diagnostyka Consilio.
What industry is Diagnostyka Consilio in?
Diagnostyka Consilio's product category is Pathology Laboratory Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology). Its NAICS code is 621511 and its SIC code is 8071.